Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors
- 1 May 2000
- journal article
- review article
- Published by Elsevier in Immunopharmacology
- Vol. 47 (2-3) , 127-162
- https://doi.org/10.1016/s0162-3109(00)00185-5
Abstract
No abstract availableKeywords
This publication has 252 references indexed in Scilit:
- Human TH1 and TH2 subsets: doubt no morePublished by Elsevier ,2004
- Isolation and Characterization of PDE8A, a Novel Human cAMP-Specific PhosphodiesteraseBiochemical and Biophysical Research Communications, 1998
- VA-045, a novel apovincamic acid derivative attenuates neuronal injury induced by hypoxia or by excitatory amino acids in cultures of rat corticesLife Sciences, 1996
- The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-α-primed neutrophil oxidative activityInternational Journal of Immunopharmacology, 1995
- Cytokine production by phytohemagglutinin-stimulated human blood cells: Effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitorsInflammation Research, 1995
- Pharmacological inhibition of CD28-stimulated T cell activationInflammation Research, 1995
- Pulmonary antiallergic and antiinflammatory effects of a novel, orallyactive phosphodiesterase IV inhibitor (WAY-127093B) in guinea pigs and ratsInflammation Research, 1995
- Interferon‐γ and lipopolysaccharide reduce cAMP responses in cultured glial cells: Reversal by a type IV phosphodiesterase inhibitorGlia, 1995
- Atopic dermatitis: New therapeutic considerationsJournal of the American Academy of Dermatology, 1991
- Concanavalin A stimulates the rolipram-sensitive isoforms of cyclic nucleotide phosphodiesterase in rat thymic lymphocytesBiochemical and Biophysical Research Communications, 1990